On ECHEMI
Home > Drugs > Bezafibrate

Bezafibrate

Indication

Used to treat hypertriglyceridemia, hypercholesterolemia, and combined hyperlipidemia.

Precautions

1. Patients who are allergic to bezafibrate are prohibited from using this product. 2. Patients with gallbladder disease or cholelithiasis are prohibited from using this product, as this product may aggravate the symptoms of gallbladder disease. 3. Patients with hepatic insufficiency or primary biliary cirrhosis are prohibited from using this product. 4. Patients with severe renal insufficiency are prohibited from using this product, as this product may cause rhabdomyolysis and severe hyperkalemia in patients with renal insufficiency. Patients with nephrotic syndrome causing hypoalbuminemia are prohibited from using this product, as this product increases the risk of myopathy. 5. Women who are breastfeeding should not use this product. 6. Children should not use this product.

Special Population Medication

Precautions for children: Not suitable for children. Precautions for pregnancy and lactation: Not suitable for lactating women.

Manufacturer

Zhejiang Jiuzhou Pharmaceutical Co., Ltd.

  • Founded in:

    1998-07-13
  • Address:

    Waisha Industrial Zone, Jiaojiang District, Taizhou City, Zhejiang Province
  • Tax NO.:

    91330000704676703E
  • Registered Funds:

    895.235828 yuan
  • Website:

  • Email:

Other Drugs of Zhejiang Jiuzhou Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.